openPR Logo
Press release

Explore the Milestones of Scientific Contribution against Cancer Evolution at Epigenetics and Cancer 2018

05-07-2018 08:55 PM CET | Science & Education

Press release from: Conferenceseries LLC Ltd

Cancer- a malady, progress and future outlook: Epigenetics and Cancer 2018 @Tokyo

Cancer- a malady, progress and future outlook: Epigenetics and Cancer 2018 @Tokyo

May 5th, 2018 Tokyo, Japan: Conference Series LLC Ltd invites all the participants from all over the world to attend 2nd International Conference on Cancer Genetics & Epigenetics during November 12th-13th, 2018 in Tokyo, Japan. It includes Keynote Presentations, Poster Presentations, E-poster, Oral talks, Workshop, and Exhibitions.

The attendees can find-
• Exclusive Sessions and Panel discussions on latest innovations in Epigenetics, Cancer Treatment, Cancer Surgery, Clinical Trials, Nursing Research & Patient Advocacy
• Lectures by active practitioners
• Keynote forums by Prominent Surgeons
• Open Innovation Challenges
• Poster presentations by Young Researchers
• Global Networking sessions with 50+ Countries
• Novel techniques to benefit your research
• Best platform for Global business and Networking opportunities
• Meet the editors of referred journals, Society and Association members across the Globe
• Excellent platform to showcase the latest products and formulations in Cosmetic Industry

The scientific program will focus on current advances in the research and leading strategies in cancer treatment with a theme “The Milestones of Scientific Contribution against Cancer Evolution: Research, Trials, Patient Advocacy & Nursing”. The conference highlights are: Cancer Evolution, Cancer Research and Trials, Cancer Surgery, Cancer Genomics and Epigenomics, Epigenetics and Cancer, Epigenomic Effects of Environmental Exposures, Biomarkers, Epigenetic Biomarkers in Cancer, Nursing and Patient Advocacy, Nursing education and research, Oncology nursing and many more.

The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Cancer genetics and Epigenetics.

Epigenetics and Cancer 2018 is a leading platform and must attend event for Professors, Physicians, Pharmacists, Scientists, Clinical Fellows, Research and Diagnostic Laboratories. It provides an interactive forum with thought leaders presenting on Cancer Evolution, Research and Trials, Surgery, Epigenetics, Biomarkers, Nursing Practices and Patient Advocacy and application in Pharmaceutical and Life Sciences Industry.
The conference focuses on the wider aspect of the scientific contribution to showcase the new scientific and technical advances in comparison to the ancient theories. Your perspective and our visualization together will set a platform for the exchange of ideas towards contribution to advanced innovation.
WHO SHOULD ATTEND?
1. Scientists
2. Professors
3. Doctors
4. Students
5. Nurses
6. Patient Advocates
7. Business delegates

Conference Insight:
• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 20+ Exhibitors
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings
The event is exclusively supported Epigenetics, Oncology Societies and Associations. Conference also offers Exhibition and Sponsorship opportunity for the interested organizations.

If you would like to know more information about this conference, to book a slot, Sponsorship and Exhibit sales information,
Please Contact: Evangeline White
Tel.: +1650-889-4686
Email: worldepigenetics@oncologymeet.com | worldepigenetics@cancersummit.org
Or
Visit: https://epigeneticsconference.conferenceseries.com/

Epigenetics and Cancer 2018 conference is organized by Conference Series LLC Ltd which is comprised of 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field all over the globe.

Conferenceseries LLC Ltd
47 Churchfield Road, London, W3 6AY

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Explore the Milestones of Scientific Contribution against Cancer Evolution at Epigenetics and Cancer 2018 here

News-ID: 1040409 • Views:

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top